Illumina launches dataset to speed up AI-powered drug discovery

Gene sequencing company Illumina on Tuesday introduced a ‍dataset that maps genetic changes to help accelerate drug discovery ⁠through artificial intelligence.

The company said it was partnering with drugmakers AstraZeneca, Merck and Eli Lilly for its Billion Cell Atlas, which will ‌train advanced ‌AI models at scale and advance research into fundamental disease mechanisms that have ‌previously been out of reach.